VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors

NEXT STORY
Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout
PREV STORY
Global Disease Analysis Report on Seasonal Influenza Vaccines – Cidara & Janssen To Tackle Flu With Antiviral Conjugates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ThromboGenics Business Update – FY 2017

Press release                                                          15 March 2018Regulated Information Advancing Preclinical and Clinical Diabetic Eye Disease Portfolio ...

author_avatar
NASDAQ Market News

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis

author_avatar
NASDAQ Market News

RNAi Therapeutics Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Molecule Type ; Application ; Route of Administration ; End User, and Geography

author_avatar
NASDAQ Market News